Holen Sie sich die Stockscreener-App
141.43
1.40%
1.95
Handel nachbörslich:
141.43
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$139.48
Offen:
$139.69
24-Stunden-Volumen:
729.90K
Relative Volume:
1.88
Marktkapitalisierung:
$9.32B
Einnahmen:
$3.55B
Nettoeinkommen (Verlust:
$370.24M
KGV:
25.81
EPS:
5.48
Netto-Cashflow:
$355.96M
1W Leistung:
+2.09%
1M Leistung:
-10.43%
6M Leistung:
-0.94%
1J Leistung:
-2.04%
1-Tages-Spanne:
$139.25
$141.44
1-Wochen-Bereich:
$138.91
$142.05
52-Wochen-Spanne:
$130.85
$178.03
Aptargroup Inc Stock (ATR) Company Profile
Firmenname
Aptargroup Inc
Sektor
Telefon
(815) 477-0424
Adresse
265 EXCHANGE DRIVE, CRYSTAL LAKE, IL
Vergleichen Sie ATR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATR
Aptargroup Inc
|
141.43 | 9.19B | 3.55B | 370.24M | 355.96M | 5.48 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Aptargroup Inc Stock (ATR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-07 | Eingeleitet | Raymond James | Outperform |
| 2025-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-14 | Hochstufung | Jefferies | Hold → Buy |
| 2024-04-29 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-01-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-08-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-04-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-10-14 | Eingeleitet | Seaport Global Securities | Neutral |
| 2020-04-27 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-25 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-03-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-02-26 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-07-08 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-04-05 | Bestätigt | BofA/Merrill | Underperform |
| 2019-02-27 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-05-18 | Eingeleitet | Jefferies | Hold |
| 2016-12-07 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2016-10-13 | Eingeleitet | Jefferies | Hold |
| 2016-01-05 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2015-11-02 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2015-09-15 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2015-05-01 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2013-02-19 | Bestätigt | Deutsche Bank | Hold |
| 2013-01-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2012-07-10 | Herabstufung | KeyBanc Capital Mkts | Buy → Hold |
| 2012-04-11 | Eingeleitet | KeyBanc Capital Mkts | Buy |
| 2011-06-13 | Hochstufung | KeyBanc Capital Mkts | Hold → Buy |
Alle ansehen
Aptargroup Inc Aktie (ATR) Neueste Nachrichten
Is AptarGroup Inc. gaining market shareQuarterly Profit Report & High Return Trade Guides - newsyoung.net
Is AptarGroup, Inc. (NYSE:ATR) Trading At A 36% Discount? - 富途牛牛
AptarGroup (ATR) Gets Buy Rating from Blair, Supported by Attractive Valuation - MSN
Pharmaceutical Packaging Market Trends and Company Analysis - GlobeNewswire
Pharmaceutical Packaging Market Trends and Company Analysis Report 2025-2033 Featuring Amcor, 3M, Schott, WestRock, Berry Global, McKesson, AptarGroup, Klockner Pentaplast, CCL, FlexiTuff - Yahoo Finance
13 Best Defensive Stocks to Invest in According to Analysts - Insider Monkey
5 Dividend Aristocrats with Capital Gains Potential - AInvest
AptarGroup (NYSE:ATR) sheds 12% this week, as yearly returns fall more in line with earnings growth - simplywall.st
AptarGroup Inc Reports Strong Q2 2025 Earnings Despite Challenges - AInvest
AptarGroup Reports Strong Q2 2025 Results - TipRanks
Analysts' Opinions on Bausch + Lomb Corporation, Avantor, and AptarGroup: A Mixed Bag - AInvest
Aptar Earnings: Growth Resumes As Beauty and Closures Rebound - Morningstar
AptarGroup expects Q3 adjusted EPS of $1.53–$1.61 while navigating inventory headwinds and litigation costs - MSN
What makes AptarGroup Inc. stock price move sharplyBuild your wealth with consistent stock growth - Jammu Links News
Is it the right time to buy AptarGroup Inc. stockBuild a portfolio that stands the test of time - Jammu Links News
When is AptarGroup Inc. stock expected to show significant growthBreakout stock performance - Jammu Links News
Is AptarGroup Inc. stock overvalued or undervaluedCapitalize on emerging investment opportunities - Jammu Links News
How strong is AptarGroup Inc. company’s balance sheetExtraordinary market timing - Jammu Links News
What are the latest earnings results for AptarGroup Inc.Get daily updates on market movers and shakers - Jammu Links News
Does AptarGroup Inc. stock perform well during market downturnsExceptional return forecasts - Jammu Links News
What catalysts could drive AptarGroup Inc. stock higher in 2025Jaw-dropping returns - Jammu Links News
AptarGroup's 2025 Q2 Earnings and Strategic Positioning: Navigating Supply Chain Shifts While Delivering Sustainable Growth - AInvest
AptarGroup, Inc. (NYSE:ATR) Q2 2025 Earnings Call Transcript - Insider Monkey
AptarGroup's Q3 Earnings Outlook: Navigating Legal and Market Headwinds While Maintaining Growth Momentum - AInvest
AptarGroup Inc (ATR) Q2 2025 Earnings Call Highlights: Strong Growth and Strategic Expansions ... - Yahoo Finance
AptarGroup (ATR): Navigating Short-Term Headwinds to Unlock Long-Term Growth in Pharma Innovation - AInvest
AptarGroup Inc (ATR) Q2 2025 Earnings Call Highlights: Strong Growth and Strategic Expansions ... By GuruFocus - Investing.com Canada
SWK Holdings Finalizes Asset Sale to AptarGroup - MSN
AptarGroup Earnings Call: Pharma and Closures Shine - TipRanks
AptarGroup (ATR) Q2 Revenue Rises 6% - The Motley Fool
AptarGroup's Q2 2025: Unpacking Contradictions in Pharma Growth, Legal Costs, and Beauty Segment Challenges - AInvest
Research Alert: Aptargroup Posts 15th Consecutive Eps Beat With Accelerating Margin Expansion - 富途牛牛
What is AptarGroup Inc. company’s growth strategySmart Portfolio Recommendation For Beginners - jammulinksnews.com
Relative Strength Alert For AptarGroup - Nasdaq
AptarGroup Q2 2025 Earnings Preview - MSN
Aptar Launches Bio-based Nasal Spray Packaging Solution - PlasticsToday
APTARGROUP, INC. SEC 10-Q Report - TradingView
Earnings call transcript: AptarGroup Q2 2025 beats EPS forecast, shares dip By Investing.com - Investing.com South Africa
Earnings call transcript: AptarGroup Q2 2025 beats EPS forecast, shares dip - Investing.com Australia
What are the technical indicators suggesting about AptarGroup Inc.Stock Strategy Trend Scanner To Watch Now - Jammu Links News
Why AptarGroup (ATR) is a Top Growth Stock for the Long-Term - Yahoo Finance
How does AptarGroup Inc. compare to its industry peersExpert Picks Data Feed From AI Tools - Jammu Links News
AptarGroup Surpasses Q2 Earnings Forecasts with Strong PerformanceNews and Statistics - IndexBox
AptarGroup Lifts Sales And Profit On Pharma Demand In Q2 - Finimize
AptarGroup: Q2 Earnings Snapshot - CTPost
AptarGroup Q2 2025 slides: All segments deliver growth, margins expand By Investing.com - Investing.com South Africa
AptarGroup Q2 2025 slides: All segments deliver growth, margins expand - Investing.com
Is this a good reentry point in AptarGroup Inc.Trade Ready Stock Watch for Short Term Published - metal.it
Aptargroup Inc reports results for the quarter ended June 30Earnings Summary - TradingView
AptarGroup (ATR) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Aptar Reports Second Quarter 2025 Results - Aptar
Finanzdaten der Aptargroup Inc-Aktie (ATR)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):